Filing Details
- Accession Number:
- 0001104659-13-048729
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-12 21:11:49
- Reporting Period:
- 2013-06-10
- Filing Date:
- 2013-06-12
- Accepted Time:
- 2013-06-12 21:11:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1471518 | Louise S. Phanstiel | C/O Verastem, Inc., 215 First Street, Suite 440 Cambridge MA 02142 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-06-10 | 4,000 | $9.16 | 4,000 | No | 4 | P | Indirect | By The Phanstiel Trust U/A/D 02/05/02 |
Common Stock | Acquisiton | 2013-06-11 | 8,000 | $9.37 | 12,000 | No | 4 | P | Indirect | By The Phanstiel Trust U/A/D 02/05/02 |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By The Phanstiel Trust U/A/D 02/05/02 |
No | 4 | P | Indirect | By The Phanstiel Trust U/A/D 02/05/02 |
Footnotes
- Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $8.86 to $9.325, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 1 to this Form 4.
- Represents a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $9.22 to $9.465, inclusive. For all transactions reported in this Form 4 utilizing a weighted-average price, the reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 2 to this Form 4.